A potential role of ruxolitinib in leukemia

Author： Naqvi Kiran Verstovsek Srdan Kantarjian Hagop Ravandi Farhad

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.8, 2011-08, pp. : 1159-1166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amonafide: a potential role in treating acute myeloid leukemia

By Allen Steven L Lundberg Ante S

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 995-1003

Informa Healthcare

Access to resources Recommend Favorite

Ruxolitinib: In the Treatment of Myelofibrosis

By Yang Lily P.H. Keating Gillian M.

Drugs, Vol. 72, Iss. 16, 2012-11 ,pp. : 2117-2127

Adis International

Access to resources Recommend Favorite

Diterpenoids- Potential Chemopreventive and Chemotherapeutic Agents in Leukemia

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 2, 2014-02 ,pp. : 127-142

Bentham Science Publishers

Access to resources Recommend Favorite

The expanding role of nilotinib in chronic myeloid leukemia

By Kim Theo Daniel Coutre Philipp le

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 97-107

Informa Healthcare

Access to resources Recommend Favorite

Leukemia Cell Differentiation - possible role of the proteasome pathway

By James S.Y. Williams M.A. Newland A.C. Colston K.W.

General Pharmacology, Vol. 32, Iss. 1, 1999-01 ,pp. : 143-154

Elsevier

Access to resources Recommend Favorite